Skip to content
10-K

Annual Report

NEUROCRINE BIOSCIENCES INC NBIX

0000914475-26-000007

← back to feed
Filed
Feb 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 4, 2026 100.36M sh
Shares Diluted FY 2025 · Dec 31, 2025 102.5M sh
Shares Diluted FY 2025 · Dec 31, 2024 103.7M sh
Shares Diluted FY 2025 · Dec 31, 2023 101M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $167.7M
Stock Repurchased FY 2025 · Dec 31, 2024 $300M
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $34M
Capex FY 2025 · Dec 31, 2024 $38.2M
Capex FY 2025 · Dec 31, 2023 $28.3M
Operating Cash Flow FY 2025 · Dec 31, 2025 $782.7M
Operating Cash Flow FY 2025 · Dec 31, 2024 $595.4M
Operating Cash Flow FY 2025 · Dec 31, 2023 $389.9M
Cash And Equivalents FY 2025 · Dec 31, 2025 $713M
Cash And Equivalents FY 2025 · Dec 31, 2024 $233M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.25B
Stockholders Equity FY 2025 · Dec 31, 2024 $2.59B
Stockholders Equity FY 2025 · Dec 31, 2023 $2.23B
Stockholders Equity FY 2025 · Dec 31, 2022 $1.71B
Current Liabilities FY 2025 · Dec 31, 2025 $743.4M
Current Liabilities FY 2025 · Dec 31, 2024 $507.7M
Total Liabilities FY 2025 · Dec 31, 2025 $1.38B
Total Liabilities FY 2025 · Dec 31, 2024 $1.13B
Current Assets FY 2025 · Dec 31, 2025 $2.52B
Current Assets FY 2025 · Dec 31, 2024 $1.72B
Total Assets FY 2025 · Dec 31, 2025 $4.63B
Total Assets FY 2025 · Dec 31, 2024 $3.72B
Eps Diluted FY 2025 · Dec 31, 2025 $4.67
Eps Diluted FY 2025 · Dec 31, 2024 $3.29
Eps Diluted FY 2025 · Dec 31, 2023 $2.47
Eps Basic FY 2025 · Dec 31, 2025 $4.81
Eps Basic FY 2025 · Dec 31, 2024 $3.40
Eps Basic FY 2025 · Dec 31, 2023 $2.56
Sga Expense FY 2025 · Dec 31, 2025 $1.16B
Sga Expense FY 2025 · Dec 31, 2024 $1.01B
Sga Expense FY 2025 · Dec 31, 2023 $887.6M
Net Income FY 2025 · Dec 31, 2025 $478.6M
Net Income FY 2025 · Dec 31, 2024 $341.3M
Net Income FY 2025 · Dec 31, 2023 $249.7M
Operating Income FY 2025 · Dec 31, 2025 $619.1M
Operating Income FY 2025 · Dec 31, 2024 $570.5M
Operating Income FY 2025 · Dec 31, 2023 $250.9M
Cost Of Revenue FY 2025 · Dec 31, 2025 $52.1M
Cost Of Revenue FY 2025 · Dec 31, 2024 $34M
Cost Of Revenue FY 2025 · Dec 31, 2023 $39.7M
Revenue FY 2025 · Dec 31, 2025 $2.86B
Revenue FY 2025 · Dec 31, 2024 $2.36B
Revenue FY 2025 · Dec 31, 2023 $1.89B